Fiorino, G.; Sturniolo, G.C.; Bossa, F.; Cassinotti, A.; Di Sabatino, A.; Giuffrida, P.; Danese, S.
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis. Cells 2019, 8, 523.
https://doi.org/10.3390/cells8060523
AMA Style
Fiorino G, Sturniolo GC, Bossa F, Cassinotti A, Di Sabatino A, Giuffrida P, Danese S.
A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis. Cells. 2019; 8(6):523.
https://doi.org/10.3390/cells8060523
Chicago/Turabian Style
Fiorino, Gionata, Giacomo Carlo Sturniolo, Fabrizio Bossa, Andrea Cassinotti, Antonio Di Sabatino, Paolo Giuffrida, and Silvio Danese.
2019. "A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis" Cells 8, no. 6: 523.
https://doi.org/10.3390/cells8060523
APA Style
Fiorino, G., Sturniolo, G. C., Bossa, F., Cassinotti, A., Di Sabatino, A., Giuffrida, P., & Danese, S.
(2019). A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis. Cells, 8(6), 523.
https://doi.org/10.3390/cells8060523